
347.39MUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US98943L1070
CUSIP
98943L107
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
2.57
Dividend Share
-
Dividend Yield
-
Earnings Share
-1.81
Wall Street Target Price
6.50
EPS Estimate Current Year
-1.74
EPS Estimate Next Year
-1.56
EPS Estimate Current Quarter
-0.5233
EPS Estimate Next Quarter
-0.4614
Most Recent Quarter
-
Revenue TTM
26,865,000
Gross Profit TTM
26,865,000
EBITDA
-141,476,000
Profit Margin
0.00%
Return On Assets TTM
-27.88%
Return On Equity TTM
-51.93%
Revenue Per Share TTM
0.374
Qtly Revenue Growth YOY
0.00%
Diluted Eps TTM
-1.81
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
7.133
Price Book MRQ
1.9016
Enterprise Value Revenue
0
Enterprise Value EBITDA
-2
489.00
0.74%666.13
0.30%880.45
0.30%935.38
0.00%86.38
0.00%135.97
-4.74%282.93
-4.69%301.50
-3.32%21.59
-1.64%185.00
-0.88%